Prof Lars Lund (Karolinska Institute, SE) outlines the findings of the ALLEVIATE-HF-1 and ALLEVIATE-HF-2 studies at 6 months. Presented at Heart Failure 22, this study aimed to evaluate a no-implant shunt in patients with chronic heart failure.
Discussion Points:
1. Aims of This Study
2. No-Implant Interatrial Shunt
3. Inclusion and Exclusion Criteria, Patient Cohort and Study Design
4. Key Findings
5. Take-Home Messages
6. Next Steps
Recorded on-site at Heart Failure 2022, Madrid.
Videographers: Tom Green & Oliver Miles
Interviewer: Mirjam Boros